United States· US:0054-0812_05eb3847-557f-460c-951f-e614fb9f9045
pyrazinamide
A pyrazinamide product containing pyrazinamide, registered in United States by Hikma Pharmaceuticals USA Inc. The same ATC class is registered in 14 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Pyrazinamide is registered in 14 of 19 countries.
Countries holding a registration under ATC J04AK01 (pyrazinamide), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 8 of them publish a price we can compare per daily dose
Pyrazinamide · ATC J04AK01
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of pyrazinamide costs, country by country.
Normalised to the WHO defined daily dose (1.5 g), the median price runs from $0.61 in France to $3.20 in Switzerland — a ×5.2 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Pyrazinamide · price per daily dose (1.5 g)
USD · FX 28 Sept 2026
- CH Switzerland$3.20
- FR France$0.61
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- PYRAZINAMIDE
- Manufacturer
- Hikma Pharmaceuticals USA Inc
- Country
- United States (US)
- ATC code
- J04AK01
- ATC class
- Pyrazinamide
- Defined daily dose
- 1.5 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 8
- ndc110054-0812-21
- ndc110054-0812-29
- ndc11005408122160 TABLET in 1 CONTAINER (0054-0812-21)
- ndc11005408122290 TABLET in 1 CONTAINER (0054-0812-22)
- ndc110054081225100 TABLET in 1 CONTAINER (0054-0812-25)
- ndc110054081229500 TABLET in 1 CONTAINER (0054-0812-29)
- ndc110054-0812-22
- ndc110054-0812-25
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
81 interactions on record for pyrazinamide.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pyrazinamide · interactions on record
81 records
- 4 severe
- 19 moderate
- 54 info
Most severe, free to view
- LeflunomidL04AA13severe
- TeriflunomidL04AA31severe
- LeflunomideL04AK01severe
- TeriflunomideL04AK02severe
4 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Pyrazinamide in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomPyrazinamide 500mg tabletsA A H Pharmaceuticals Ltd
- FinlandPyrazinamidPharmacal Oy Ab
- FrancePIRILENE 500 mg, compriméSANOFI WINTHROP INDUSTRIE
- SwitzerlandPyrazinamide Labatec 500 mg, comprimésLabatec Pharma SA
- NetherlandsPyrazinamide CF 500 mg, tablettenCentrafarm B.V.
- NorwayPyrazinamide jenapharmJenapharm GmbH & Co. KG
- PolandPyrazinamid FarmapolPrzedsiębiorstwo Farmaceutyczne Farmapol Sp. z o.o.
- CzechiaPYRAZINAMID KRKA
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Austria · Pyrafat
- Belgium · Tebrazid
- Bulgaria · Пиразинамид Крка
- Germany · Pyrafat, Pyrazinamid Jenapharm
- Denmark · Pyrazinamid Sad
- Spain · Pirazinamida Prodes
- Finland · Tisamid
- France · Pirilene
- United Kingdom (Northern Ireland) · Pyrazinamide Morningside Healthcare
- Greece · Pyrazinamide Genepharm
- Croatia · Pyrazinamid Krka
- Lithuania · Pyrafat, Pyrazinamide Krka
- Luxembourg · Tebrazid
- Latvia · Pyrazinamide Olpha
- Malta · Pyrazinamide Morningside Healthcare
- Netherlands · Pyrazinamide Cf
- Poland · Pyrazinamid Farmapol
- Portugal · Pramide
- Romania · Pirazinamida Atb
- Slovenia · Pirazinamid Krka
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/68d1f913-8a54-407c-81f2-939c13c93e24 GET /v1/drugs/68d1f913-8a54-407c-81f2-939c13c93e24?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "500",
"substance": "PYRAZINAMIDE",
"productndc": "0054-0812",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA081319",
"marketing_category": "ANDA"
}See everything about pyrazinamide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.